FewerJobs.
All jobs

Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

AstraZeneca - Cambridge MA – 100 Binney Street

Posted Nov 3, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Nov 20, 2026
Salary
Not verified
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Role

Seniority
Staff Plus From the posting source checked Nov 16, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience Cambridge MA – 100 Binney Street Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience Location: Cambridge, MA AstraZeneca is seeking a highly motivated and scientifically rigorous postdoctoral fellow to join the Oncology Bioscience group in Cambridge. This position sits at the intersection of cancer biology and innate immunology, centered on a mechanistically novel discovery: that inhibition of a first-in-class kinase target can regulate tumor growth both through direct cell autonomous oncogenic signaling and non-cancer cell autonomous modulation of the innate immune system. This work is built around a potent and selective first-in-class AstraZeneca compound, grounded in compelling preliminary in vivo data demonstrating that target inhibition drives tumor regression through innate immune engagement in multiple myeloma models. The postdoc will characterize this mechanism, identify the specific innate immune cell types responsible, and evaluate rational combination strategies with T-cell directed therapies. This is a rare opportunity to lead a mechanistically novel program with direct translational relevance, publish in high-impact journals, and work alongside experts in oncology. This postdoc role will report to Kayleigh Gallagher (Associate Principal Scientist) and be supported by Omid Tavana (Senior Director) at AstraZeneca. Major Responsibilities Lead in vivo studies in syngeneic and xenograft mouse models to establish and characterize the non-cancer cell autonomous function of a first-in-class kinase inhibitor in multiple myeloma Dissect the mechanistic contribution of individual innate immune cell types through CRISPR-based models, immune cell depletion, and reconstitution experiments Apply advanced immunophenotyping and transcriptomic platforms, including CyTOF, single-cell RNA-seq, and

Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.

Apply at astrazeneca.wd3.myworkdayjobs.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs